8-K
AMBARELLA INC RI false 0001280263 0001280263 2021-03-02 2021-03-02

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

March 2, 2021

Date of Report (date of earliest event reported)

 

 

AMBARELLA, INC.

(Exact name of Registrant as specified in its charter)

 

 

 

Cayman Islands   001-35667   98-0459628
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (I. R. S. Employer
Identification No.)

3101 Jay Street

Santa Clara, CA 95054

(Address of principal executive offices)

Registrant’s telephone number, including area code: (408) 734-8888

N/A

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange
on which registered

Ordinary Shares, $0.00045 par value   AMBA   The Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 


Item 2.02

Results of Operations and Financial Condition

On March 2, 2021, Ambarella, Inc. issued a press release announcing its results for the fourth quarter and fiscal year 2021 ended January 31, 2021. A copy of the press release is attached as Exhibit 99.1 to this current report on Form 8-K and is incorporated by reference herein.

The information in this current report on Form 8-K and the exhibits attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.

 

Item 9.01

Financial Statements and Exhibits

(d) Exhibits

 

99.1    Press Release dated March 2, 2021
104    Cover Page Interactive Data File, formatted in inline XBRL.

Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: March 2, 2021       Ambarella, Inc.
     

/s/ Kevin C. Eichler

     

Kevin C. Eichler

Chief Financial Officer

EX-99.1

Exhibit 99.1

Ambarella, Inc. Announces Fourth Quarter and Fiscal Year 2021 Financial Results

Contact:

Louis Gerhardy

408.636.2310

lgerhardy@ambarella.com

SANTA CLARA, CALIF.— March 2, 2021—Ambarella, Inc. (Nasdaq: AMBA), an AI vision silicon company, today announced financial results for its fourth quarter of fiscal year 2021 ending January 31, 2021.

 

   

Revenue for the fourth quarter of fiscal 2021 was $62.1 million, up 9% from $57.2 million in the same period in fiscal 2020. For the fiscal year ending January 31, 2021, revenue was $223.0 million, down 3% from $228.7 million for the fiscal year ending January 31, 2020.

 

   

Gross margin under U.S. generally accepted accounting principles (GAAP) for the fourth quarter of fiscal 2021 was 60.8%, compared with 58.2% for the same period in fiscal 2020. For the fiscal year ending January 31, 2021, GAAP gross margin was 60.8%, compared with 58.0% for the fiscal year ending January 31, 2020.

 

   

GAAP net loss for the fourth quarter of fiscal 2021 was $12.5 million, or loss per diluted ordinary share of $0.35, compared with a GAAP net loss of $13.0 million, or loss per diluted ordinary share of $0.39, for the same period in fiscal 2020. GAAP net loss for the fiscal year ending January 31, 2021 was $59.8 million, or loss per diluted ordinary share of $1.72. This compares with GAAP net loss of $44.8 million, or loss per diluted ordinary share of $1.35, for the fiscal year ending January 31, 2020.

Financial results on a non-GAAP basis for the fourth quarter of fiscal 2021 are as follows:

 

   

Gross margin on a non-GAAP basis for the fourth quarter of fiscal 2021 was 61.4%, compared with 58.7% for the same period in fiscal 2020. For the fiscal year ending January 31, 2021, non-GAAP gross margin was 61.4%, compared with 58.5% for the fiscal year ending January 31, 2020.

 

   

Non-GAAP net income for the fourth quarter of fiscal 2021 was $5.1 million, or earnings per diluted ordinary share of $0.14. This compares with non-GAAP net income of $4.9 million, or earnings per diluted ordinary share of $0.14, for the same period in fiscal 2020. Non-GAAP net income for the fiscal year ending January 31, 2021 was $11.9 million, or earnings per diluted ordinary share of $0.33. This compares with non-GAAP net income of $23.7 million, or earnings per diluted ordinary share of $0.69, for the fiscal year ending January 31, 2020.

Based on information available as of today, Ambarella is offering the following guidance for the first quarter of fiscal year 2022, ending April 30, 2021:

 

   

Revenue is expected to be between $67.0 million and $70.0 million

 

   

Gross margin on a non-GAAP basis is expected to be between 59.5% and 61.5%

 

   

Non-GAAP operating expenses are expected to be between $34.0 million and $36.0 million


Ambarella reports gross margin, net income (loss) and earnings (losses) per share in accordance with GAAP and, additionally, on a non-GAAP basis. Non-GAAP financial information excludes the impact of stock-based compensation adjusted for the associated tax impact, which includes the effect of any benefits or shortfalls recognized. A reconciliation of the GAAP to non-GAAP gross margin, net income (loss) and earnings (losses) per share for the periods presented, as well as a description of the items excluded from the non-GAAP calculations, is included in the financial statements portion of this press release.

Total cash, cash equivalents and marketable securities on hand at the end of the fourth quarter of fiscal 2021 was $440.7 million, compared with $404.7 million at the end of the same quarter a year ago.

“Demand for our AI vision silicon products accelerated in FY21 with more than 175 unique customers purchasing engineering parts and/or development systems, including more than 40 who reached production volumes. Cumulatively, we expect to have shipped more than 2 million computer vision SoCs by the end of Q1, with more than 300,000 CV SoCs shipped into the automotive market,” said Fermi Wang, President and CEO. “In FY22 we intend to continue to build on our AI vision momentum, driving CV to at least 25% of revenue, while maintaining a high level of execution in the face of the ongoing public health, geopolitical and supply-chain challenges.”

Stock Repurchase

In the fourth quarter of fiscal year 2021, the company did not repurchase shares. During fiscal year 2021, the company repurchased 25,719 shares for total consideration of approximately $1.0 million. During the second quarter of fiscal year 2021, Ambarella’s Board of Directors approved an extension of the prior $50.0 million repurchase program for an additional twelve months ending June 30, 2021. As of today, there are approximately $49.0 million available for repurchases under the program. The repurchase program does not obligate the company to acquire any particular amount of ordinary shares, and it may be suspended at any time at the company’s discretion.

Quarterly Conference Call

Ambarella plans to hold a conference call at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time today with Fermi Wang, President and Chief Executive Officer, and Casey Eichler, Chief Financial Officer, to discuss the fourth quarter and fiscal year 2021 results. The call can be accessed by dialing 877-304-8963 in the USA; international callers should dial 760-666-4834. Please dial in ten minutes prior to the scheduled conference call time. A live and archived webcast of the call will be available on Ambarella’s website at http://www.ambarella.com/ for up to 30 days after the call.

About Ambarella

Ambarella’s products are used in a wide variety of human and computer vision applications, including video security, advanced driver assistance systems (ADAS), electronic mirror, drive recorder, driver/cabin monitoring, autonomous driving, and robotic applications. Ambarella’s low-power System- on-Chips (SoCs) offer high-resolution video compression, advanced image processing, and powerful deep neural network processing to enable intelligent cameras to extract valuable data from high-resolution video streams. For more information, please visit www.ambarella.com


“Safe harbor” statement under the Private Securities Litigation Reform Act of 1995

This press release contains forward-looking statements that are not historical facts and often can be identified by terms such as “outlook,” “projected,” “intends,” “will,” “estimates,” “anticipates,” “expects,” “believes,” “could,” or similar expressions, including the guidance for the first quarter of fiscal year 2022 ending April 30, 2021, and the comments of our CEO relating to the Company’s ability to generate revenue from its computer vision, or CV, products, the Company’s expectations of future volumes of CV product shipments, including shipments into the automotive market, the percentage of total revenue that may be derived from CV products, and the Company’s ability to maintain its level of execution. The achievement or success of the matters covered by such forward-looking statements involves risks, uncertainties and assumptions. Our actual results could differ materially from those predicted or implied and reported results should not be considered as an indication of our future performance.

The risks and uncertainties referred to above include, but are not limited to, risks associated with revenue being generated from new customers or design wins, neither of which is assured; the commercial success of our customers’ products; risks associated with the COVID-19 virus and its impact on the global economy or any of our operations or the operations of our customers; risks associated with the semiconductor supply chain, including the ability of our suppliers to meet our demand; our growth strategy; global economic and political conditions, including possible trade tariffs, trade restrictions and export controls that impact our products, our customers or our customers’ products; our ability to anticipate future market demands and future needs of our customers; our ability to introduce new and enhanced solutions; our ability to develop, and to generate revenue from, new advanced technologies, such as computer vision functionality; our ability to retain and expand customer relationships and to achieve design wins; the expansion of our current markets and our ability to successfully enter new markets, such as the OEM automotive and robotics markets; anticipated trends and challenges, including competition, in the markets in which we operate; our ability to effectively manage growth; our ability to retain key employees; and the potential for intellectual property disputes or other litigation.

Further information on these and other factors that could affect our financial results is included in the company’s Annual Report on Form 10-K for our 2020 fiscal year, which is on file with the Securities and Exchange Commission. Additional information is also set forth in the company’s quarterly reports on Form 10-Q, annual reports on Form 10-K and other filings the company makes with the Securities and Exchange Commission from time to time, copies of which may be obtained by visiting the Investor Relations portion of our web site at www.ambarella.com or the SEC’s web site at www.sec.gov. Undue reliance should not be placed on the forward-looking statements in this release, which are based on information available to us on the date hereof. The results we report in our Annual Report on Form 10-K for the fiscal year ending January 31, 2021 could differ from the preliminary results announced in this press release.


Ambarella assumes no obligation and does not intend to update the forward-looking statements made in this press release, except as required by law.

Non-GAAP Financial Measures

The company has provided in this release non-GAAP financial information, including non-GAAP gross margin, net income, and earnings per share, as a supplement to the consolidated financial statements, which are prepared in accordance with generally accepted accounting principles (“GAAP”). Management uses these non-GAAP financial measures internally in analyzing the company’s financial results to assess operational performance and liquidity. The company believes that both management and investors benefit from referring to these non-GAAP financial measures in assessing its performance and when planning, forecasting and analyzing future periods. Further, the company believes these non-GAAP financial measures are useful to investors because they allow for greater transparency with respect to key financial metrics that the company uses in making operating decisions and because the company believes that investors and analysts use them to help assess the health of its business and for comparison to other companies. Non-GAAP results are presented for supplemental informational purposes only for understanding the company’s operating results. The non-GAAP information should not be considered a substitute for financial information presented in accordance with GAAP, and may be different from non-GAAP measures used by other companies.

With respect to its financial results for the fourth quarter of fiscal year 2021, the company has provided below reconciliations of its non-GAAP financial measures to its most directly comparable GAAP financial measures. With respect to the company’s expectations for the first quarter of fiscal year 2022, a reconciliation of non-GAAP gross margin and non-GAAP operating expenses guidance to the closest corresponding GAAP measure is not available without unreasonable efforts on a forward-looking basis due to the high variability and low visibility with respect to the charges excluded from these non-GAAP measures. We expect the variability of the above charges to have a significant, and potentially unpredictable, impact on our future GAAP financial results.


AMBARELLA, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except share and per share data)

(unaudited)

 

     Three Months Ended January 31,     Twelve Months Ended January 31,  
     2021     2020     2021     2020  

Revenue

   $ 62,142     $ 57,212     $ 222,990     $ 228,732  

Cost of revenue

     24,339       23,896       87,417       96,023  
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

     37,803       33,316       135,573       132,709  
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating expenses:

        

Research and development

     37,184       33,807       140,759       129,724  

Selling, general and administrative

     14,632       13,341       55,980       52,634  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     51,816       47,148       196,739       182,358  

Loss from operations

     (14,013     (13,832     (61,166     (49,649

Other income, net

     632       1,713       3,863       8,021  
  

 

 

   

 

 

   

 

 

   

 

 

 

Loss before income taxes

     (13,381     (12,119     (57,303     (41,628

Provision (benefit) for income taxes

     (892     862       2,483       3,164  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net loss

   $ (12,489   $ (12,981   $ (59,786   $ (44,792
  

 

 

   

 

 

   

 

 

   

 

 

 

Net loss per share attributable to ordinary shareholders:

        

Basic

   $ (0.35   $ (0.39   $ (1.72   $ (1.35
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted

   $ (0.35   $ (0.39   $ (1.72   $ (1.35
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted-average shares used to compute net loss per share attributable to ordinary shareholders:

        

Basic

     35,338,351       33,677,059       34,679,717       33,083,562  
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted

     35,338,351       33,677,059       34,679,717       33,083,562  
  

 

 

   

 

 

   

 

 

   

 

 

 

The following table presents details of stock-based compensation expense included in each functional line item in the consolidated statements of operations above:

 

     Three Months Ended January 31,      Twelve Months Ended January 31,  
     2021      2020      2021      2020  
            (unaudited, in thousands)         

Stock-based compensation:

           

Cost of revenue

   $ 347      $ 262      $ 1,328      $ 1,184  

Research and development

     11,501        10,536        42,903        41,842  

Selling, general and administrative

     6,879        6,105        25,903        23,845  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total stock-based compensation

   $ 18,727      $ 16,903      $ 70,134      $ 66,871  
  

 

 

    

 

 

    

 

 

    

 

 

 

The difference between GAAP and non-GAAP gross margin was 0.6% and 0.5%, or $0.347 million and $0.262 million, for the three months ending January 31, 2021 and 2020, respectively. The difference between GAAP and non-GAAP gross margin was 0.6% and 0.5%, or $1.3 million and $1.2 million, for the fiscal years ending January 31, 2021 and 2020, respectively. The differences were due to the effect of stock-based compensation.


AMBARELLA, INC.

RECONCILIATION OF GAAP TO NON-GAAP DILUTED EARNINGS (LOSSES) PER SHARE

(in thousands, except share and per share data)

 

     Three Months Ended January 31,     Twelve Months Ended January 31,  
     2021     2020     2021     2020  
     (unaudited)  

GAAP net loss

   $ (12,489   $ (12,981   $ (59,786   $ (44,792

Non-GAAP adjustments:

        

Stock-based compensation expense

     18,727       16,903       70,134       66,871  

Income tax effect

     (1,092     942       1,513       1,576  
  

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP net income

   $ 5,146     $ 4,864     $ 11,861     $ 23,655  
  

 

 

   

 

 

   

 

 

   

 

 

 

GAAP - diluted weighted average shares

     35,338,351       33,677,059       34,679,717       33,083,562  

Non-GAAP - diluted weighted average shares

     37,569,396       35,094,270       35,994,296       34,313,148  

GAAP - diluted net loss per share

   $ (0.35   $ (0.39   $ (1.72   $ (1.35

Non-GAAP adjustments:

        

Stock-based compensation expense

     0.53       0.50       2.02       2.02  

Income tax effect

     (0.03     0.03       0.04       0.05  

Effect of Non-GAAP - diluted weighted average shares

     (0.01     —         (0.01     (0.03

Non-GAAP - diluted net income per share

   $ 0.14     $ 0.14     $ 0.33     $ 0.69  


AMBARELLA, INC.

CONSOLIDATED BALANCE SHEETS

(unaudited, in thousands)

 

     January 31,
2021
     January 31,
2020
 

ASSETS

     

Current assets:

     

Cash and cash equivalents

   $  241,274      $  231,403  

Marketable debt securities

     199,434        173,345  

Accounts receivable, net

     24,974        18,487  

Inventories

     26,081        22,971  

Restricted cash

     10        9  

Prepaid expenses and other current assets

     5,531        4,975  
  

 

 

    

 

 

 

Total current assets

     497,304        451,190  

Property and equipment, net

     5,530        5,614  

Deferred tax assets, non-current

     10,914        10,400  

Intangible assets, net

     18,703        17,826  

Operating lease right-of-use assets, net

     9,659        9,935  

Goodwill

     26,601        26,601  

Other non-current assets

     4,569        5,710  
  

 

 

    

 

 

 

Total assets

   $ 573,280      $ 527,276  
  

 

 

    

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

     

Current liabilities:

     

Accounts payable

     21,124        14,910  

Accrued and other current liabilities

     48,126        34,970  

Operating lease liabilities, current

     2,911        2,181  

Income taxes payable

     962        691  

Deferred revenue, current

     844        701  
  

 

 

    

 

 

 

Total current liabilities

     73,967        53,453  

Operating lease liabilities, non-current

     7,525        7,975  

Other long-term liabilities

     16,812        17,776  
  

 

 

    

 

 

 

Total liabilities

     98,304        79,204  
  

 

 

    

 

 

 

Shareholders’ equity:

     

Preference shares

     —          —    

Ordinary shares

     16        15  

Additional paid-in capital

     347,458        261,220  

Accumulated other comprehensive income

     1,219        768  

Retained earnings

     126,283        186,069  
  

 

 

    

 

 

 

Total shareholders’ equity

     474,976        448,072  
  

 

 

    

 

 

 

Total liabilities and shareholders’ equity

   $ 573,280      $ 527,276